EyeGene Inc. (KOSDAQ:185490)
1,450.00
-21.00 (-1.43%)
At close: Apr 2, 2026
EyeGene Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10,194 | 1,425 | 5,496 | 2,046 | 2,649 |
Short-Term Investments | 33,300 | 31,122 | 49,872 | 59,080 | 72,680 |
Trading Asset Securities | 2,002 | - | - | 5,329 | 10,027 |
Cash & Short-Term Investments | 45,497 | 32,547 | 55,368 | 66,455 | 85,357 |
Cash Growth | 39.79% | -41.22% | -16.68% | -22.14% | 163.86% |
Accounts Receivable | 772.12 | 1,415 | 468.06 | 898.07 | 731.32 |
Other Receivables | 167.4 | 312.04 | 428.64 | 486.97 | 296.1 |
Receivables | 939.53 | 1,727 | 896.7 | 1,385 | 1,027 |
Inventory | 750.72 | 584.99 | 55.21 | 498.01 | 774.4 |
Prepaid Expenses | 307.95 | 149.19 | 240.5 | - | - |
Other Current Assets | 141.88 | 289.3 | 317.01 | 492.77 | 1,485 |
Total Current Assets | 47,637 | 35,298 | 56,877 | 68,830 | 88,644 |
Property, Plant & Equipment | 5,992 | 9,315 | 9,851 | 5,742 | 5,864 |
Long-Term Investments | 7,746 | 14,159 | 9,337 | 3,807 | 4,076 |
Other Intangible Assets | 2,901 | 4,281 | 982.61 | 844.1 | 761.27 |
Other Long-Term Assets | 3,750 | 2,150 | 1,055 | 1,158 | 5,646 |
Total Assets | 68,051 | 65,306 | 78,103 | 80,381 | 104,991 |
Accounts Payable | 1,301 | 1,680 | 470.69 | 863.84 | 1,894 |
Accrued Expenses | 302.65 | 252.29 | 341.29 | 343.29 | 361.43 |
Short-Term Debt | - | 1,773 | 1,498 | 1,392 | 2,995 |
Current Portion of Leases | 168.61 | 179.6 | 314.49 | 392.85 | 272.63 |
Current Unearned Revenue | 1.33 | 0.64 | 3.33 | 3.2 | 3.16 |
Other Current Liabilities | 6,318 | 5,534 | 5,634 | 1,924 | 4,083 |
Total Current Liabilities | 8,092 | 9,419 | 8,262 | 4,920 | 9,609 |
Long-Term Leases | 391.62 | 487.56 | 338.43 | 611.41 | 676.06 |
Pension & Post-Retirement Benefits | 2,915 | 2,546 | 3,485 | 4,613 | 4,055 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 1,168 |
Other Long-Term Liabilities | 490.9 | 437.83 | 626.99 | 1,281 | 513.64 |
Total Liabilities | 11,889 | 12,891 | 12,713 | 11,426 | 16,022 |
Common Stock | 21,615 | 13,515 | 13,515 | 10,739 | 10,705 |
Additional Paid-In Capital | 202,340 | 188,325 | 188,329 | 176,131 | 176,277 |
Retained Earnings | -177,465 | -161,740 | -149,862 | -129,722 | -103,829 |
Comprehensive Income & Other | 10,637 | 10,221 | 11,248 | 9,580 | 5,816 |
Total Common Equity | 57,127 | 50,321 | 63,230 | 66,728 | 88,969 |
Minority Interest | -2,875 | 513.52 | 1,104 | 2,228 | - |
Shareholders' Equity | 56,162 | 52,415 | 65,390 | 68,956 | 88,969 |
Total Liabilities & Equity | 68,051 | 65,306 | 78,103 | 80,381 | 104,991 |
Total Debt | 560.24 | 2,441 | 2,151 | 2,397 | 3,943 |
Net Cash (Debt) | 44,936 | 30,107 | 53,217 | 64,058 | 81,413 |
Net Cash Growth | 49.26% | -43.43% | -16.92% | -21.32% | 434.64% |
Net Cash Per Share | 1607.93 | 1114.59 | 2458.55 | 2987.22 | 4298.37 |
Filing Date Shares Outstanding | 30.62 | 27.03 | 27.03 | 21.48 | 21.41 |
Total Common Shares Outstanding | 30.62 | 27.03 | 27.03 | 21.48 | 21.41 |
Working Capital | 39,545 | 25,878 | 48,615 | 63,911 | 79,034 |
Book Value Per Share | 1865.45 | 1861.69 | 2339.28 | 3106.77 | 4155.60 |
Tangible Book Value | 54,226 | 46,040 | 62,248 | 65,884 | 88,208 |
Tangible Book Value Per Share | 1770.70 | 1703.31 | 2302.93 | 3067.47 | 4120.04 |
Machinery | 10,803 | 13,374 | 13,392 | 7,251 | 6,154 |
Construction In Progress | - | - | - | 102.83 | 613.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.